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Introduction: Pseudomonas aeruginosa is the most common opportunistic pathogen associated 
with a broad range of infections, including cystic fibrosis, ocular, otitis media, and burn infec-
tions. The aim of this study was to show the frequency of the pilS2 gene, and its association with 
P. aeruginosa plasmid pKLC102 and PAPI-1 pathogenicity island among P. aeruginosa strains.
Methods: The samples were collected from patients with cystic fibrosis, ocular, otitis media, 
and burn infections between January 2016 and November 2017. DNA was extracted using the 
DNA extraction kit and was used for PCR assay. PCR with 4 primer-pairs including 976 F/PAPI-
1R, 4542 F/intF, SojR/4541 F, and intF/sojR was performed to identify PAPI-1. pKLC102 was 
detected using three other primer-pairs including cp10F/ cp10R, cp44F/cp44R, and cp97F/cp97R.
Results: A total of 112 P. aeruginosa isolates were collected from patients with cystic fibrosis 
(36), burn (20), otitis media (26), and ocular (30) infections. The results of PCR showed that 
pilS2 gene was identified in 96 (85%) strains. PAPI-1–attB integration was detected among 38 
(33.9%) isolates and the circular form of PAPI-1 detected among 17 (14%) isolates. In addition, 
79 (70.5%) strains were found to be positive for pKLC102.
Conclusion: We found that the majority of the isolates may be susceptible to transfer this sig-
nificant island and the related element pKLC102 into recipient isolates lacking the island owing 
to high association of the PilS2 pilus with the islands in the studied strains. It is anticipated 
that strains isolated from burn and eye with the highest rate of PilS2, PAPI-1, and pKLC102 
association have a high level of antibiotic resistance.
Keywords: Pseudomonas aeruginosa, pilS2, cystic fibrosis, pKLC102, PAPI-1
Introduction
Pseudomonas aeruginosa (P. aeruginosa) is the most common bacterial pathogen 
associated with persistent bronchial infections among cystic fibrosis patients.1 This 
pathogen is capable of causing several infections including nosocomial pneumonia, 
nosocomial urinary tract infections, acute diffuse otitis media, conjunctivitis, and 
keratitis.2–4 The pathogenesis of P. aeruginosa is due to the production of extracellular 
virulence factors (such as pili, hemolysins, pyocyanin, proteases, alginate, lipopoly-
saccharide, and the Type III secretion system) and effector proteins (such as ExoU, 
ExoT, ExoY, and ExoS).5,6
P. aeruginosa isolates have shown the ability of adherence to different receptors 
and production of biofilm by Type IV pili.7 Type IV pili has two major subfamilies 
including Type IVa (T4aP) and IVb (T4bP). T4bP are a more heterogeneous group, 
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whereas T4aP are a somewhat homogeneous and Tad pili (a 
monophyletic class of T4bP) were seen in a broad variety of 
environmental species.8
Although T4aP- and Tad-encoding genes are found in all 
the P. aeruginosa isolates, the gene encoding major subunit of 
the Type IVb pili (pilS2 gene) is seen in the strains that have 
related elements such as P. aeruginosa plasmid pKLC102 
or PAPI-1 pathogenicity island.8,9 Carter et al showed that 
PAPI-1 can be transferred to other P. aeruginosa strains fol-
lowing excision from the chromosome of the donor. Also, 
they demonstrated that PAPI-1 is transferred into recipient P. 
aeruginosa by a conjugative mechanism, via a Type IV pilus, 
encoded in PAPI-1 by a ten-gene cluster (8).
There are two tRNALys genes located in the P. aerugi-
nosa genome, known as PA0976.1 and PA4541.1. pKLC102 
is a 103,532 bp integrative and conjugative element that 
integrates into one of these positions.10 However, PAPI-1 
can integrate into the attB sites of the both PA0976.1 and 
PA4541.1 positions.11 In addition to this integrated form 
of PAPI-1, the island can also exist in some populations of 
bacteria as an extrachromosomal circular form.12
Interestingly, the 10 PAPI-1-encoded pilus proteins are 
well conserved in several P. aeruginosa strains that carry this 
island, including PA2192, PA7, C3710, PACS2, and PSE9 
(PAGI-5), and in P. aeruginosa clone C strain that carry a 
pKLC102-like element.
The PAPI-1 pilS2 gene encodes for a major pilin subunit, 
which is a 176-amino-acid protein containing a conserved 
PilS superfamily domain. Horizontal gene transfer is known 
as a main evolutionary mechanism and contributes to the 
virulence properties of many bacterial pathogens (V).
There is no specific study on the prevalence of the pilS2 
gene and its association with P. aeruginosa plasmid pKLC102 
and PAPI-1 pathogenicity island among P. aeruginosa in Iran. 
This study could be the basis for further research in the future.
So, the aim of this study was to evaluate the prevalence 
of the pilS2 gene, and its association with P. aeruginosa 
plasmid pKLC102 and PAPI-1 pathogenicity island among P. 
aeruginosa strains isolated from patients with cystic fibrosis, 
ocular, otitis media, and burn infections.
Methods
study design, data, and specimens 
collection
A prospective cross-sectional study was conducted between 
January 2016 and November 2017. The research was 
approved by the ethical committee of Shahid Beheshti 
University of Medical Sciences, Tehran, Iran with ethics 
number: IR.SBMU.RETECH.REC.1395.460. As a part of 
the Shahid Beheshti University of Medical Sciences policy, 
written informed consent was obtained from all patients. The 
study was conducted in accordance with the Declaration of 
Helsinki. The clinical samples were collected from inpatients 
with otitis media, burn wound infections, keratitis, and cystic 
fibrosis who were hospitalized in Shahid Motahari Hospital 
(level I burn care center). The sputum samples of the patients 
with cystic fibrosis were examined macroscopically for the 
presence of salivary contamination. Following this, briefly, 
sputum was incubated with an equal volume of sputolysin for 
15 minutes at room temperature and plated onto chocolate 
agar. The deep oropharyngeal swab samples were collected 
and cultured on blood agar and MacConkey agar media 
(Merck, Germany).13
For bacterial isolation from the burn patients, surface 
culture swabs were collected from them and were inoculated 
onto blood agar, MacConkey agar, and tryptic soy broth 
media (Merck, Germany).14 The ocular specimens from the 
patients with conjunctivitis and keratitis were collected by an 
ophthalmic surgeon and ophthalmologist. These specimens 
were transferred into 2 mL of brain-heart infusion broth 
(Oxoid, Hampshire, UK).15
The outer ear of the patients with otitis media was cleaned 
with normal saline and the pus discharges were collected 
with sterile cotton swab sticks. Pus swabs were added to 
stuart transport medium (Merck, Germany) and cultured 
on blood agar, chocolate agar, and MacConkey agar media 
(Merck, Germany).16
The isolated colonies from the positive cultures were 
investigated for biochemical characteristics of P. aeruginosa. 
Briefly, the biochemical tests include gram staining, pigment 
production, colony morphology, growth at 42°C on Mueller–
Hinton agar, the ability of oxidase and catalase production, 
and oxidative-fermentative test.1
antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using 
the Kirby–Bauer disk diffusion method according to Clini-
cal & Laboratory Standards Institute17 recommendations. 
The susceptibilities of all isolates to different antibiotics 
were determined using cefepime (30 µg), amikacin (30 µg), 
ceftazidime (30 µg), tobramycin (10 µg), ciprofloxacin (5 µg), 
meropenem (10 µg), cefoperazone (75 µg), piperacillin (100 
µg), imipenem (10 µg), gentamicin (10 µg), ceftazidime (30 
µg), piperacillin-tazobactam (110/10 µg), colistin (10 µg), 
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Relationship of pilS2 gene with P. aeruginosa plasmid pKLC102 and PAPI-1
Dna extraction and PcR
The clinical samples were cultured on chocolate agar medium 
and the isolated single colonies of P. aeruginosa were incu-
bated in 5 mL Luria–Bertani medium at 37°C overnight. 
Then, DNA templates were prepared using the DNA extrac-
tion kit (Genet Bio Company, Korea, Cat. No, K-3000) as 
previously described.18
PCR assay with four primer-pairs including 976F/PAPI-
1R, 4542F/intF, SojR/4541F, and intF/sojR was performed 
to identify the P. aeruginosa PAPI-1 pathogenicity island.
Likewise, P. aeruginosa plasmid pKLC102 was detected 
using three other primer-pairs including cp10F/ cp10R, 
cp44F/cp44R, and cp97F/cp97R by PCR method. Primer 
sequence used in the genetic characterization of P. aeruginosa 
clinical strains and for detecting the pilS2 gene is shown in 
Table 1. Amplified products were analyzed by electrophore-
sis on 1% agarose gel containing safe stain, and finally in 
the case of DNA replication and seeing the sharp band, it is 
considered as positive.
Data analysis
The data were analyzed using the SPSS statistical package 
version 22 (IBM SPSS Statistics, USA) and Microsoft excel 
2016 (Microsoft Corporation, USA) statistical software. 
The results are presented as descriptive statistics in terms of 
relative frequency.
Results
A total of 112 P. aeruginosa isolates were collected from 
different sources, of which 36 were isolated from patients 
with cystic fibrosis, 20 from burn wound infections, 26 from 
otitis media, and 30 from ocular infections.
Antibiotic susceptibility tests using the Kirby–Bauer 
method revealed that the highest resistance percentage was 
related to cefepime, gentamicin, and ciprofloxacin 99 (88%), 
followed by meropenem and imipenem 98 (87%). The results 
showed that colistin and cefoperazone-sulbactam were the 
best antibiotics against P. aeruginosa isolates. Antibiotic 
resistance patterns are detailed in Table 2.
Table 1 Primer sequence used in the genetic characterization of Pseudomonas aeruginosa clinical strains
Gene/genomic 
islands
Forward primer sequence (5′–3′) Reverse primer sequence (5′–3′) Size of PCR product 
(bp)
Tm ( oC)
pilS2 gcggTTTcgTTTccaTcgag ggTcacTTcTccggTgaTcg 428 60
pKlc102
cp10 cggaccacTagaTagccagg ggacgccaTTgagTaTgcgc 255 61
cp44 gggTccgcaaaacTTTccgc gcTTgaggTTgggccaaTcg 272 61
cp97 ggaTaTcTacgTaccccggc cTTTTTacccgcagTggcgg 337 61
PaPI-1
976F/PaPI-1R gccTgacggTgTccTgTTaT gcTgccTcTccTacgaaca 2,600 58
4542F/intF gTggTgaTgaccTccaaccT agcTacaTcgaggccgacTa 1,600 58
sojR/4541F cgagcacagaaaTgTccTga gacaagaccagccacaaccT 1,600 58
intF/sojR agcTacaTcgaggccgacTa cgagcacagaaaTgTccTga 1,600 58
Table 2 antibiotic resistance patterns in Pseudomonas aeruginosa isolates
Antibiotic Cystic fibrosis
N (%)








cotrimoxazole 27 (75) 17 (85) 22 (84) 22 (73) 88 (79)
cefoperazone-sulbactam 17 (47) 9 (45) 12 (46) 14 (46) 52 (46)
amikacin 24 (66) 16 (80) 19 (73) 25 (83) 84 (75)
Piperacillin-tazobactam 28 (77) 16 (80) 20 (76) 23 (76) 87 (77)
Piperacillin 32 (88) 14 (70) 21 (80) 24 (80) 91 (79)
cefepime 31 (86) 17 (85) 22 (84) 29 (96) 99 (88)
Tobramycin 23 (63) 10 (50) 11 (42) 17 (56) 61 (54)
Meropenem 33 (91) 17 (85) 22 (84) 26 (86) 98 (87)
Imipenem 33 (91) 17 (85) 22 (84) 26 (86) 98 (87)
gentamicin 34 (94) 16 (80) 23 (88) 26 (86) 99 (88)
ceftazidime 22 (61) 14 (70) 22 (84) 24 (80) 82 (73)
colistin 0 (0) 0 (0) 2 (7) 3 (10) 5 (4)
Ciprofloxacin 33 (91) 18 (90) 21 (80) 27 (90) 99 (88)
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Frequency of the pilS2 gene
The results showed that the pilS2 gene was identified in 
85% (n=96) of the P. aeruginosa strains. This major subunit 
of Type IVb pili was detected among 24% (n=23) of the P. 
aeruginosa strains isolated from cystic fibrosis patients, 21% 
(n=20) isolated from burn patients, 31% (n=30) isolated from 
patients with ocular infections, and 24% (n=23) isolated from 
patients with otitis media. Agarose gel electrophoresis of 
PCR products after amplification of the pilS2 gene is shown 
in Figure 1.
Frequency of the P. aeruginosa PaPI-1 
pathogenicity island
Overall, the integration of the PAPI-1 to the attB site of posi-
tions PA0976.1 and PA4541.1 was identified among 33.9% 
(n=38) of P. aeruginosa isolates. Approximately 18.5% (n=7) 
of the strains were isolated from cystic fibrosis patients, 
39.5% (n=15) isolated from burn patients, 21% (n=8) isolated 
from patients with ocular infections, and 21% (n=8) isolated 
from patients with otitis media.
In addition, the PCR assay using primer-pair intF/sojR 
has detected the circular form of PAPI-1 among 14% (n=17) 
of P. aeruginosa strains isolated from hospitalized patients 
(including six cystic fibrosis patients, six burn patients, and 
five patients with ocular infections).
Frequency of the P. aeruginosa plasmid 
pKlc102
Overall, 70.5% (n=79) of the P. aeruginosa strains were 
found to be positive for pKLC102. The highest frequency 
of this element was detected among patients with ocular 
(34%) and burn (25%) infections, followed by cystic fibrosis 
(22%) and otitis media (19%). The results of PCR method 
for identification of the pKLC102 demonstrated that CP10, 
CP44, and CP97 genes were present in 49%, 51%, and 17% 
of the P. aeruginosa strains, respectively (Table 2). Agarose 
gel electrophoresis of PCR products after amplification of the 
CP44 and CP10 genes is shown in Figures 2 and 3.
The association of the pilS2 gene with 
pKlc102
The pilS2 gene was simultaneously associated with pKLC102 
in 75 (70%) isolates, of which 27 (36%), 19 (25.4%), 15 
(20%), and 14 (18.6%) were detected from ocular, burn, otitis 
media, and cystic fibrosis infections, respectively (Table 3).
The association of the pilS2 gene with 
PaPI-1 and pKlc102
In this study, 36 (32.1%) P. aeruginosa strains encoded all 
pKLC102, chromosomal PAPI1, plasmid PAPI1, and pilS2 
genes. Moreover, the pKLC102+, chromosomal PAPI1–, plas-
428 bp
1 2 3 4 5 6 P N
Figure 1 Detection of pils2 gene (428 bp) in Pseudomonas aeruginosa isolates.
Notes: 1–3 and 5 positive samples, 4 and 6 negative samples; molecular pattern: 
100 bp.
Abbreviations: n, negative control; P, positive control.
272 bp
1 2 3 4 5 6 7 8 9 P N
Figure 2 Detection of CP44 gene (272 bp) in Pseudomonas aeruginosa isolates. 
Note: Molecular pattern: 100 bp.
Abbreviations: n, negative control; P, positive control.
255 bp
1 2 3 4 5 6 7 8 9 10 11 12 13 N P
Figure 3 Detection of CP10 gene (255 bp) in Pseudomonas aeruginosa isolates.
Note: Molecular pattern: 100 bp.
Abbreviations: n, negative control; P, positive control.
Table 3 Frequency of the specific genes CP10, cP44, and cP97 
of pKlc102
Genotype CF Eye Ear Burn Total (%)
cp10– cp44– cp97– 18 3 11 1 33 (29.4)
cp10+ cp44– cp97– 6 9 2 4 21 (18.7)
cp10– cp44+ cp97– 9 0 0 2 11 (9.8)
cp10– cp44– cp97+ 0 0 0 0 0
cp10+ cp44+ cp97– 3 16 0 9 28 (25)
cp10+ cp44– cp97+ 0 0 0 1 1 (0.9)
cp10– cp44+ cp97+ 0 1 12 0 13 (11.6)
cp10+ cp44+ cp97+ 0 1 1 3 5 (4.4)
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Relationship of pilS2 gene with P. aeruginosa plasmid pKLC102 and PAPI-1
mid PAPI1+, pilS2+ genotype was the most frequent among 
the isolates (Table 4).
The association of the pKlc102 with 
PaPI-1
The results showed that all the P. aeruginosa strains that 
are pKLC102 positive encoded also the PAPI-1 element. 
Although among 37 (33%) strains, pKLC102 was associ-
ated with both the chromosomal and plasmid PAPI-1, in 41 
(36.6%) strains, pKLC102 was present along with only the 
plasmid form of the PAPI-1 (Table 5).
Discussion
P. aeruginosa is an opportunistic human pathogen capable of 
causing a broad range of human life-threatening acute and 
chronic infections.19 The bacterium is capable of inhabiting 
a wide range of environmental niches, in part, owing to have 
a diverse genomic repertoire that encodes multiple virulence 
factors such as Type IVb pilus, which is encoded by the 
island PAPI-1.6 Also, this pathogen can adhere to different 
receptors and produce biofilm by its extracellular virulence 
factor, Type IV pili.20
The current study showed the frequency of the gene 
encoding major subunit of the Type IVb pili, the pilS2 gene, 
and its association with P. aeruginosa plasmid pKLC102 
and PAPI-1 pathogenicity island among P. aeruginosa strains 
isolated from patients with cystic fibrosis, keratitis, otitis 
media, and burn infection. The results demonstrated that 
85% of the P. aeruginosa strains encoded the pilS2 gene. 
Indeed, 21% (n=20) and 31% (n=30) of the P. aeruginosa 
strains isolated from patients with burn and ocular infections 
were pilS2-positive. Furthermore, patients with otitis media 
(88.4) and cystic fibrosis (63.8) also had a high prevalence 
of the pilS2 gene.
These findings are comparable with the study performed 
by Dabiri et al,14 in Iran. They evaluate the Type IV pilin sub-
groups in P. aeruginosa strains and showed that pilS2 gene 
was found among 67.5% of cystic fibrosis and 73.3% of burn 
Table 4 The association of pils2 with pKlc102, chromosomal PaPI-1, and plasmid PaPI-1
Genotype Cystic fibrosis 
N (%)
Eye N (%) Ear N (%) Burn N (%) Total N 
(%)
pKlc102– chromosomal PaPI1– plasmid PaPI1– pils2– 6 (16.6) 0 3 (11.5) 0 9 (8)
pKlc102+ chromosomal PaPI1– plasmid PaPI1– pils2– 0 0 0 0 0
pKlc102– chromosomal PaPI1+ plasmid PaPI1– pils2– 3 (8.3) 0 0 0 3 (2.6)
pKlc102– chromosomal PaPI1– plasmid PaPI1+ pils2– 0 0 0 0 0
pKlc102– chromosomal PaPI1– plasmid PaPI1– pils2+ 3 (8.3) 3 (10) 4 (15.3) 0 10 (8.9)
pKlc102+ chromosomal PaPI1+ plasmid PaPI1– pils2– 0 0 0 0 0
pKlc102+ chromosomal PaPI1– plasmid PaPI1+ pils2– 3 (8.3) 0 0 0 3 (2.6)
pKlc102+ chromosomal PaPI1– plasmid PaPI1– pils2+ 0 0 0 0 0
pKlc102– chromosomal PaPI1+ plasmid PaPI1+ pils2– 0 0 0 0 0
pKlc102– chromosomal PaPI1+ plasmid PaPI1– pils2+ 6 (16.6) 0 4 (15.3) 1 (5) 11 (9.8)
pKlc102– chromosomal PaPI1– plasmid PaPI1+ pils2+ 0 0 0 0 0
pKlc102+ chromosomal PaPI1+ plasmid PaPI1+ pils2– 1 (2.7) 0 0 0 1 (0.8)
pKlc102+ chromosomal PaPI1+ plasmid PaPI1– pils2+ 0 0 0 0 0
pKlc102+ chromosomal PaPI1– plasmid PaPI1+ pils2+ 11 (30.5) 17 (56.6) 6 (23) 5 (25) 39 (38.8)
pKlc102– chromosomal PaPI1+ plasmid PaPI1+ pils2+ 0 0 0 0 0
pKlc102+ chromosomal PaPI1+ plasmid PaPI1+ pils2+ 3 (8.3) 10 (33.3) 9 (34.6) 14 (70) 36 (32)
Table 5 The association of pKlc102 with chromosomal PaPI-1 and plasmid PaPI-1
Genotype Cystic fibrosis N (%) Eye N (%) Ear N (%) Burn N (%) Total N 
(%)
pKlc102– chromosomal PaPI1– plasmid PaPI1– 9 (25) 3 (10) 7 (26.9) 0 19 (16.9)
pKlc102+ chromosomal PaPI1– plasmid PaPI1– 0 0 0 0 0
pKlc102– chromosomal PaPI1+ plasmid PaPI1– 9 (25) 0 4 (15.3) 1 (5) 14 (12.5)
pKlc102– chromosomal PaPI1– plasmid PaPI1+ 0 0 0 0 0
pKlc102+ chromosomal PaPI1+ plasmid PaPI1– 0 0 0 0 0
pKlc102+ chromosomal PaPI1– plasmid PaPI1+ 14 (38.8) 17 (56.6) 6 (23) 5 (25) 42 (37.5)
pKlc102– chromosomal PaPI1+ plasmid PaPI1+ 0 0 0 0 0
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patients. In this manner, regarding the importance of Type IV 
pili in virulence and pathogenesis of P. aeruginosa, the results 
highlight the need for a main program for identification of this 
pilin and urgently interventions to prevent the development 
of P. aeruginosa strains isolated from hospitalized patients.
In a study by Sadeghifard et al21 in 2012, the existence 
of PAPI-1 in clinical P. aeruginosa isolates was evaluated; 
in that study, 35% of isolates were positive for this genomic 
island, so that most of the PAPI-1-positive isolates showed 
high levels of antibiotic resistance. In another study done 
by Morales-Espinosa et al in Mexico, the genetic and phe-
notypic features of 100 P. aeruginosa isolates were studied. 
They have detected PAPI-1 among 81% of the isolates. This 
island was reported to be integrated into the chromosome at 
locus PA0976.1 and PA4541.1 among 65% and 16% of the 
strains, respectively. However, the circular form of PAPI-1 
was not found in any of the strains.22
In addition, in Morales-Espinosa et al’s work, 87% of iso-
lates carried pKLC102, so that CP10, CP44, and CP97 were 
positive in 87, 88, and 70 strains, respectively, and more than 
half of the isolates carried all three genes. Also, Klockgether 
et al found 50 isolates of P. aeruginosa with pKLC102-like 
islands in their study.
Similarly, we reported that the prevalence of integrated 
form of PAPI-1 was 33.9%. This rate was the highest among 
patients with burn infection (39.5%), followed by ocular 
(21%), otitis media (21%), and cystic fibrosis (18.5%) infec-
tions. Interestingly, all isolates positive for pKLC102 in the 
current study were also shown to carry PAPI-1 (in 70.5% 
of the isolates) and this association was more frequently 
detected among eye and burn isolates (Table 4).
Furthermore, as our results revealed, the association 
of pilS2 gene with PAPI-1 and pKLC102 was found pre-
dominantly in P. aeruginosa isolates from burn (pKLC102+, 
chromosomal PAPI1+, plasmid PAPI1+, and pilS2+ genotype) 
and eye infection (pKLC102+, chromosomal PAPI1, plasmid 
PAPI1+, and pilS2+ genotype) (Table 4); taken together, in 
70.8% of the isolates, the association was established and 
in 9.8% of the isolates pilS2 gene was only associated with 
PAPI-1 (chromosomal PAPI-1).
Conclusion
In this study, we found that the majority of the isolates may 
be susceptible to transfer this significant island and the related 
element pKLC102 into recipient isolates lacking the island 
owing to high association of the PilS2 pilus with the islands 
in the studied strains, which may affect the pathogenesis of 
these isolates.
Moreover, based on this data, it is anticipated that strains 
isolated from burn and eye with the highest rate of PilS2, 
PAPI-1, and pKLC102 association have a high level of anti-
biotic resistance and a higher potential of biofilm formation. 
Regarding this, more investigations are needed to evaluate the 
frequency of PilS2, PAPI-1, and pKLC102 and its association 
with antibiotic-resistance properties and biofilm synthesis in 
P. aeruginosa isolates from Iran.
Acknowledgments
We would like to thank the Department of Microbiology, 
Faculty of Medicine, Shahid Beheshti University of Medi-
cal Sciences for their cooperation. Our appreciation goes to 
the Vice Chancellor for Research Affairs, Shahid Beheshti 
University of Medical Sciences, Tehran, Iran, and the Tropical 
and Infectious Diseases Research Center of the university for 
their financial and executive support.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Heidary M, Hashemi A, Goudarzi H, et al. The antibacterial activity 
of Iranian plants extracts against metallo beta-lactamase produc-
ing Pseudomonas aeruginosa strains. J Paramed Sci. 2016;7(1): 
13–19.
 2. Wang MC, Liu CY, Shiao AS, Wang T. Ear problems in swimmers. J 
Chin Med Assoc. 2005;68(8):347–352.
 3. Buchele MLC, Wopereis DB, Casara F, et al. Contact lens-related 
polymicrobial keratitis: Acanthamoeba spp. genotype T4 and Candida 
albicans. Parasitol Res. 2018;117(11):3431–3436.
 4. Tarashi S, Heidary M, Dabiri H, Nasiri MJ. Prevalence of drug-resistant 
Pseudomonas aeruginosa in Iranian burned patients: a meta-analysis. 
Arch Trauma Res. 2017;6(3):1–17.
 5. Chirani AS, Majidzadeh R, Pouriran R, et al. The effect of in silico target-
ing Pseudomonas aeruginosa patatin-like protein D, for immunogenic 
administration. Comput Biol Chem. 2018;74:12–19.
 6. Harrison EM, Carter ME, Luck S, et al. Pathogenicity islands PAPI-1 and 
PAPI-2 contribute individually and synergistically to the virulence of Pseu-
domonas aeruginosa strain PA14. Infect Immun. 2010;78(4):1437–1446.
 7. Rasamiravaka T, Labtani Q, Duez P, El Jaziri M. The formation of 
biofilms by Pseudomonas aeruginosa: a review of the natural and 
synthetic compounds interfering with control mechanisms. Biomed 
Res Int. 2015;2015(1):1–17.
 8. Carter MQ, Chen J, Lory S. The Pseudomonas aeruginosa pathogenic-
ity island PAPI-1 is transferred via a novel type IV pilus. J Bacteriol. 
2010;192(13):3249–3258.
 9. Würdemann D, Tümmler B. In silico comparison of pKLC102-like 
genomic islands of Pseudomonas aeruginosa. FEMS Microbiol Lett. 
2007;275(2):244–249.
 10. Klockgether J, Reva O, Larbig K, Tümmler B. Sequence analysis of 
the mobile genome island pKLC102 of Pseudomonas aeruginosa C. J 
Bacteriol. 2004;186(2):518–534.
 11. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of 
Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 
2000;406(6799):959–964.
 12. Qiu X, Gurkar AU, Lory S. Interstrain transfer of the large pathogenicity 





































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Infection and Drug Resistance  2019:12 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Infection and Drug Resistance 
Publish your work in this journal
Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journal
Infection and Drug Resistance is an international, peer-reviewed open-
access journal that focuses on the optimal treatment of infection (bacte-
rial, fungal and viral) and the development and institution of preventive 
strategies to minimize the development and spread of resistance. The 
journal is specifically concerned with the epidemiology of antibiotic 
resistance and the mechanisms of resistance development and diffusion 
in both hospitals and the community. The manuscript management 
system is completely online and includes a very quick and fair peer-
review system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
Dovepress
227
Relationship of pilS2 gene with P. aeruginosa plasmid pKLC102 and PAPI-1
 13. Huus KE, Joseph J, Zhang L, et al. Clinical isolates of Pseudomonas 
aeruginosa from chronically infected cystic fibrosis patients fail to 
activate the inflammasome during both stable infection and pulmonary 
exacerbation. J Immunol. 2016;196(7):3097–3108.
 14. Dabiri H, Nikokar I, Dousdar F, Goudarzi H, Fallah F, Esmaili A. Evalu-
ation of type IV pilin sub groups in Pseudomonas aeruginosa isolated 
from environmental samples, cystic fibrosis and burn patients. Iran J 
Med Microbiol. 2014;8(3):1–7.
 15. Teweldemedhin M, Saravanan M, Gebreyesus A, Gebreegziabiher D. 
Ocular bacterial infections at Quiha Ophthalmic Hospital, Northern 
Ethiopia: an evaluation according to the risk factors and the antimi-
crobial susceptibility of bacterial isolates. BMC Infect Dis. 2017;17(1): 
207.
 16. Seid A, Deribe F, Ali K, Kibru G. Bacterial otitis media in all age group 
of patients seen at Dessie referral hospital, North East Ethiopia. Egypt 
J Ear Nose Throat Allied Sci. 2013;14(2):73–78.
 17. Hosseini SM, Arabestani MR, Mahmoodi H, Farhangara E. Prevalence 
of G, H, I, J. Enterotoxin genes and antibacterial susceptibility pattern 
in staphylococcus aureus strains isolated from different foods. Middle 
East J Fam Med. 2015;13(4):1–10.
 18. Khoshnood S, Eslami G, Hashemi A, et al. Distribution of amino-
glycoside resistance genes among Acinetobacter baumannii strains 
isolated from burn patients in Tehran, Iran. Arch Pediatr Infect Dis. 
2017;5(3):e577263.
 19. He J, Baldini RL, Déziel E, et al. The broad host range pathogen Pseu-
domonas aeruginosa strain PA14 carries two pathogenicity islands 
harboring plant and animal virulence genes. Proc Natl Acad Sci USA. 
2004;101(8):2530–2535.
 20. Rasamiravaka T, Vandeputte OM, Pottier L, et al. Pseudomonas aeru-
ginosa biofilm formation and persistence, along with the production 
of quorum sensing-dependent virulence factors, are disrupted by a 
triterpenoid coumarate ester isolated from Dalbergia trichocarpa, a 
tropical legume. PLoS One. 2015;10(7):e0132791.
 21. Sadeghifard N, Rasaei SZ, Ghafourian S, et al. Prevalence of genomic 
island PAPI-1 in clinical isolates of Pseudomonas aeruginosa in Iran. 
Southeast Asian J Trop Med Public Health. 2012;43(2):431–435.
 22. Morales-Espinosa R, Soberón-Chávez G, Delgado-Sapién G, et al. 
Genetic and phenotypic characterization of a Pseudomonas aerugi-





































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
